"HIV" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
MeSH Number(s)
B04.820.650.589.650.350
B04.909.777.731.589.650.350
Concept/Terms
HIV- HIV
- Viruses, Human Immunodeficiency
- AIDS Virus
- AIDS Viruses
- Virus, AIDS
- Viruses, AIDS
- HTLV-III
- Human Immunodeficiency Virus
- Human Immunodeficiency Viruses
- Human T Cell Lymphotropic Virus Type III
- Human T Lymphotropic Virus Type III
- Human T-Cell Leukemia Virus Type III
- Human T Cell Leukemia Virus Type III
- Human T-Cell Lymphotropic Virus Type III
- Human T-Lymphotropic Virus Type III
- Immunodeficiency Virus, Human
- Immunodeficiency Viruses, Human
- LAV-HTLV-III
- Lymphadenopathy-Associated Virus
- Lymphadenopathy Associated Virus
- Lymphadenopathy-Associated Viruses
- Virus, Lymphadenopathy-Associated
- Viruses, Lymphadenopathy-Associated
- Virus, Human Immunodeficiency
- Acquired Immune Deficiency Syndrome Virus
- Acquired Immunodeficiency Syndrome Virus
Below are MeSH descriptors whose meaning is more general than "HIV".
Below are MeSH descriptors whose meaning is more specific than "HIV".
This graph shows the total number of publications written about "HIV" by people in Harvard Catalyst Profiles by year, and whether "HIV" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 5 | 4 | 9 |
1994 | 3 | 0 | 3 |
1995 | 4 | 5 | 9 |
1996 | 8 | 1 | 9 |
1997 | 6 | 3 | 9 |
1998 | 7 | 4 | 11 |
1999 | 8 | 2 | 10 |
2000 | 6 | 5 | 11 |
2001 | 7 | 7 | 14 |
2002 | 13 | 5 | 18 |
2003 | 14 | 11 | 25 |
2004 | 13 | 5 | 18 |
2005 | 13 | 9 | 22 |
2006 | 17 | 6 | 23 |
2007 | 27 | 11 | 38 |
2008 | 15 | 14 | 29 |
2009 | 14 | 11 | 25 |
2010 | 27 | 11 | 38 |
2011 | 25 | 18 | 43 |
2012 | 21 | 23 | 44 |
2013 | 24 | 13 | 37 |
2014 | 18 | 19 | 37 |
2015 | 7 | 14 | 21 |
2016 | 19 | 7 | 26 |
2017 | 12 | 9 | 21 |
2018 | 19 | 50 | 69 |
2019 | 13 | 30 | 43 |
2020 | 15 | 39 | 54 |
2021 | 4 | 45 | 49 |
2022 | 4 | 30 | 34 |
2023 | 4 | 34 | 38 |
Below are the most recent publications written about "HIV" by people in Profiles.
-
Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)-Results From the MIRACLE HIV Study. Clin Infect Dis. 2023 10 13; 77(8):1166-1175.
-
T-SPOT.TB Reactivity in Southern African Children With and Without in Utero Human Immunodeficiency Virus Exposure. Clin Infect Dis. 2023 10 13; 77(8):1133-1136.
-
Electronic Antiretroviral Therapy Adherence Monitors and Associated Interventions Improve Adolescent-Caregiver Relationships and Self-Efficacy Among Adolescents and Young Adults with HIV in Uganda. AIDS Patient Care STDS. 2023 Oct; 37(10):489-494.
-
Costing of HIV services, Uganda and United Republic of Tanzania. Bull World Health Organ. 2023 Oct 01; 101(10):626-636.
-
Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa. Health Qual Life Outcomes. 2023 Aug 21; 21(1):94.
-
Associations between police harassment and distrust in and reduced access to healthcare among Black sexual minority men: A longitudinal analysis of HPTN 061. PLoS One. 2023; 18(8):e0290378.
-
The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014. PLoS One. 2023; 18(8):e0290113.
-
The Brief Human Immunodeficiency Virus (HIV) Index: A Rapid 3-Item Scale to Measure Engagement in HIV Care. Clin Infect Dis. 2023 08 14; 77(3):425-427.
-
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus. Clin Infect Dis. 2023 08 14; 77(3):414-418.
-
Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial. Obstet Gynecol. 2023 09 01; 142(3):613-624.